Tradestie Institutional Equity Comparison Engine
MNMD vs CMPS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MNMD Overall Edge
MNMD Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mind Medicine (MindMed) Inc. Common Shares (MNMD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MNMD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CMPS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MNMD sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against CMPS sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MNMD N/M vs CMPS N/M Fwd P/E
Growth & Margin Winner
MNMD
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
MNMD
1Y +131.2% vs +56.9% ยท 52W Pos 98% vs 31%
Options & Structure Winner
MNMD
UNCLASSIFIED (6th %ile IV) vs UNCLASSIFIED (16th %ile IV)
MNMD
NASDAQ
Mind Medicine (MindMed) Inc. Common Shares
Medicinal Chemicals & Botanical Products
$15.02
+1.01% 1D
Market Cap
$1.4B
1M Return
+19.54%
1Y Return
+131.25%
Forward P/E
N/M
Unified AI Score
63.1 / 100
BUY
Tech 75.0
Fund 62.0
Flow 60.0
Mom 50.0
CMPS
NASDAQ
COMPASS Pathways Plc American Depository Shares
Pharmaceutical Preparations
$8.30
-7.88% 1D
Market Cap
$1.3B
1M Return
-22.79%
1Y Return
+56.9%
Forward P/E
N/M
Unified AI Score
57.3 / 100
HOLD
Tech 65.0
Fund 60.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MNMD +131.25%
CMPS +56.9%
Spread: +15.08 pp (CMPS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MNMD TTM Op. Margin: 0.0%
CMPS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MNMD vs CMPS. Trailing 12-month operating profitability (MNMD 0.0% vs CMPS 0.0%) and valuation multiples (MNMD N/M vs CMPS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MNMD | CMPS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | $1.3B | Larger Scale | MNMD |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -85.6% | -296.4% | Higher ROE | MNMD |
| 52-Week Range Position Momentum | 98% ($5โ$15) | 31% ($5โ$16) | Stronger Trend | MNMD |
| Beta / 30D Volatility Risk Regime | 1.79ฮฒ ยท 55% Vol | 1.84ฮฒ ยท 122% Vol | Lower Realized Risk | MNMD |
| Unified Institutional Score Composite Signal | 63.1 / 100 (BUY) | 57.3 / 100 (HOLD) | Higher Composite | MNMD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MNMD vs CMPS Buy Guide
MNMD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
CMPS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MNMD nor CMPS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.